Summary: Picking the wrong blockchain partner for your healthcare app can totally mess up interoperability, security, and compliance timelines. This guide helps decision-makers figure out how to assess vendors based on 2025 healthcare standards (like TEFCA, HTI-1, DSCSA, NIST, FTC HBNR), complete with practical checks, warning signs, and sample RFP criteria based on real-world examples and up-to-date regulations.

How to Evaluate a Blockchain Healthcare App Development Partner

In 2024 and 2025, the landscape of healthcare compliance and interoperability is changing quite a bit. TEFCA has officially launched and we're seeing more and more Designated QHINs getting on board, along with a new FHIR Roadmap being published. The ONC's HTI-1 rule has locked in USCDI v3 as the baseline for 2026, plus it's pushing forward with SMART v2. On another front, the FTC wrapped up its Health Breach Notification Rule, which now clearly applies to health apps that fall outside of HIPAA. And don’t forget, the DSCSA enforcement timelines are still in play, with some exemptions based on partner types extending all the way through 2025 and 2026. So, if you’re in this space, your partner really needs to be ready to adapt to these changes from day one. You can check out more details here.

Here's a detailed, hands-on evaluation playbook that 7Block Labs uses when teaming up with startups and enterprises to find the right blockchain development partners for regulated healthcare.

---

1) Regulatory literacy: insist on specifics, not slogans

• HIPAA Security Rule Implementation Competence
  • When chatting with vendors, make sure they can break down their technical plan based on NIST SP 800‑66r2's big activities like risk analysis, access controls, and transmission security. It’s also a good idea to see how they tie this into the CPRT mappings for NIST SP 800‑53r5 controls. Don't forget to ask for a written crosswalk that explains your app's data flows. (csrc.nist.gov)
• HIPAA Privacy Rule Obligations Impacting Ledgers
  • Dig a little deeper into how they plan to handle the right to amend (check out 45 CFR 164.526) while working with an immutable ledger. Look for things like append-only "correction" records, off-chain truth sources, and how they manage Fabric private data purges (see Section 4). If they can't clearly explain their amendment workflow and how they handle auditability, you might want to raise an eyebrow. (law.cornell.edu)
• HIPAA De‑Identification Nuance
  • Make sure their team knows that just because PHI is “hashed,” it doesn't automatically mean it’s not PHI--some hashed data can still fall under that category based on how it’s derived. Insist on an Expert Determination or a strict Safe Harbor method instead of just hearing “we hashed it on-chain.” (hhs.gov)
• Non‑HIPAA Scenarios (Consumer Health Apps, Wellness, Genomics Wallets)
  • It's crucial to require a documented FTC HBNR posture, which includes details on breach notification content, timelines (keeping it to 60 days or less), and how they'll identify any third parties that received the data. A lot of blockchain health apps fall under HBNR rules, even if they don’t touch HIPAA. (ftc.gov)
• Reproductive Health PHI
  • Ask them how they plan to put the 2024 OCR final rule into practice, which restricts certain disclosures. Plus, check in on how they’re keeping tabs on the 2025 litigation that could affect parts of that rule. You’re looking for a mix of legal monitoring and technical protections like segmentation and access attestations. (hhs.gov)

Practical Acceptance Criteria:

• Within 10 working days, we need you to share a HIPAA/NIST 800‑66r2 control mapping that fits the architecture of your MVP.
• Also, please create a written FTC HBNR incident response playbook that’s specifically designed for your app's data stores and analytics.

---

2) Interoperability and TEFCA readiness: validate against today’s network, not yesterday’s pilots

• TEFCA Status Matters (For U.S. Deployments)
  • In 2023, we saw the first QHINs get officially designated, and by 2025, that list grew even more (think eClinicalWorks, Surescripts, with Netsmart stepping in as the 10th QHIN). It’s a good idea to check which QHINs your partner is working with--whether directly or through participants--and ask to see some transaction metrics from their test or production flows. You can find more about it here.
• TEFCA FHIR Roadmap Alignment
  • The RCE’s roadmap lays out how we’ll move from intra-network FHIR to QHIN-facilitated and end-to-end FHIR API exchanges. Make sure your vendor connects your use case to these stages and plans capabilities accordingly. You can dive deeper into the roadmap right here.
• HTI-1 Implications for Your APIs
  • Check in on the adoption plans for SMART App Launch v2, including those granular SMART v2 scopes and the publication of standardized FHIR endpoints. It’s important to have a strategy in place to support USCDI v3 as the baseline by January 1, 2026. More info can be found over at HIMSS.

Practical Checks:

• Get a one-page TEFCA integration plan that shows which QHIN(s) you’re working with, the exchange purpose(s), and a quick rundown of FHIR versus IHE-based flows.
• Request a demo of SMART v2 granular scopes in a sandbox (for example, allow only Observation.lab with a search filter).

---

3) Data standards: FHIR Bulk Data, directories, and imaging

• FHIR Bulk Data (Flat FHIR) for Population Analytics
  • Make sure the team has set up the Bulk Data export feature ($export) for research or quality improvement, as well as payer scenarios. It's super important to check that they’ve got proper async handling and ndjson outputs in place. Also, see if they have experience with US Core and Bulk Data IG conformance. You can find more info here.
• Validated Healthcare Directory Integration
  • For use cases around provider credentialing and keeping the network strong, ask about the HL7 Validated Healthcare Directory (VHDir) IG profiles--like Practitioner, OrganizationAffiliation, and Endpoint. It's good to know how updates make their way to on‑chain credentials or attestations. Check out the details here.
• DICOM and Imaging Governance
  • If imaging is part of the project, insist on having a solid plan for de-identifying DICOM tags (don’t forget about OCR for any burnt-in PHI) before any cryptographic commitments are locked in on‑chain. The Cloud Healthcare API capabilities should be used along with strict human review checkpoints. You can read more about this here.

Practical Checks:

• Ask for proof of Bulk Data exports that handle 10 million or more resources, along with details on their retry/back-pressure design.
• Request a VHDir data ingestion plan that outlines how license validations are passed on to verifiable credentials.

---

4) Ledger architecture for PHI: off‑chain first, privacy by design

• Keep PHI off‑chain
  • Aim for a strategy where only proofs, pointers, or selective metadata are stored on-chain. It’s best to keep PHI in FHIR stores or encrypted object stores, making sure to have strict key management and access controls in place. Don’t forget to write audit hashes or consent receipts to the ledger!
• Use permissioned stacks with mature privacy controls
  • Hyperledger Fabric is a solid choice for the healthcare sector: the current version, v2.5 LTS, has added a private data purge API, which helps with data minimization and allows for the “selective erasure” of sensitive records (but the hashes will stick around as evidence). Make sure any vendors you work with know their stuff when it comes to channel design, private data collections, and purge policies. (lf-decentralized-trust.github.io)
• Identity and credentials
  • Have a chat about how they plan to implement W3C DIDs and Verifiable Credentials for things like provider/staff credentialing or consent artifacts. VC 2.0 became a W3C Recommendation back in May 2025, so your partner should definitely aim for this baseline. (w3.org)

Practical Checks:

• Make sure to insist on a “shared nothing” breach model. This means that if there's a compromise in an FHIR store or analytics enclave, the on-chain data shouldn't be sufficient to reidentify anyone.
• Take a look at a demo for purging Fabric private data, including retention policies and evidence hashes.

---

5) Key management, crypto, and ops maturity (prove it with certifications)

• HSMs and FIPS validation
  • When it comes to signing VCs or consent receipts, make sure you're using HSM-backed key storage with FIPS 140-validated modules. AWS KMS HSM has a current FIPS 140-3 Level 3 certificate, so be sure to chat with your partner about their validation approach and what boundaries they're operating within. (csrc.nist.gov)
• HITRUST CSF awareness (not a substitute for HIPAA, but strong hygiene)
  • Nowadays, a lot of payers and providers are looking for vendors to align with HITRUST v11.x. So, don't hesitate to ask them which version of their security program they follow (v11.5/v11.6 updates are set to come out in 2025) and what kind of assessment they’re aiming for (e1/i1/r2). (hitrustalliance.net)
• Digital identity assurance
  • If your app handles identity proofing or wallets, it's essential to check that it aligns with NIST SP 800-63-4 (dropping in 2025) for IAL/AAL/FAL and that it supports passkeys and wallets mentioned in the update. (pages.nist.gov)

Practical Checks:

• Make sure to get proof of FIPS-validated cryptographic modules that are used for signing and check out the KMS-managed key rotation policies.
• Ask for a written control mapping that aligns with HITRUST v11.x, including the scope, planned assessment level, and timeline.

---

6) Advanced privacy tech: where it’s useful--and where it isn’t

• Zero-knowledge proofs (ZKPs) and confidential computation
  • When it comes to selective disclosure--think of questions like “Is this practitioner licensed?” without giving away their identity--ZKPs can really step up compliance efforts. It's a good idea to dig into the details, like how performance stacks up (proof sizes, verification latency) and where those proofs are stored (off-chain vs. on-chain). Recent studies highlight that in certain healthcare scenarios, you can achieve verification in under 100 ms with pretty compact proof sizes. Just keep in mind, the feasibility can vary based on circuit complexity. Check out more info here.
• Federated learning with verifiability
  • So, blockchain-powered federated learning can really help manage who gets to participate and offers a nice audit trail for model updates. Plus, with ZKP-assisted aggregation gaining traction, it’s becoming better at defending against tricky Byzantine participants. You might want to consider this as a roadmap unless you absolutely need multi-institution machine learning right now. Find out more here.

Practical checks:

• Start by focusing the partner on a straightforward, production-ready ZK use case, like checking license status or verifying consent age, before diving into the more complicated ML proofs.

---

7) Supply chain and DSCSA: if you touch pharmaceuticals, require EPCIS‑first designs

• Standards before chains
  • The FDA and GS1 are really pushing for EPCIS when it comes to DSCSA interoperability. A bunch of networks, whether they’re using blockchain or not, are already swapping EPCIS 1.2+ events. Before diving into any blockchain pilot, make sure you have proof of EPCIS interchange maturity and conformance testing in hand. Check out more details here.
• Timelines and exemptions
  • Don’t let your partners brush off the timing issue! The FDA set up a stabilization period that wraps up on November 27, 2024, and they’ve got exemptions in place depending on the type of trading partner. For instance, dispensers with 26 or more FTEs have until November 27, 2025, while some smaller dispensers have until November 27, 2026, to comply. Your rollout plan definitely needs to take this into account. For more info, click here.

Practical checks:

• Request proof of successful EPCIS exchanges at scale--think millions of events--and ask for GS1 US trustmarks or similar credentials. While blockchain's great for anchoring provenance or sorting out disputes, the day-to-day operations rely heavily on EPCIS. (prnewswire.com)

---

8) Cloud and data ops: de‑identification, observability, and rollback plans

• De‑identification pipelines with review gates
  • If you're diving into GCP’s Cloud Healthcare API for FHIR/DICOM de‑identification, make sure to go for configuration‑as‑code, deterministic date shifting (with managed keys) and don’t skip out on mandatory human QA for random samples in each batch. Just a heads-up: Google points out that de‑identification doesn’t necessarily equal legal compliance--so your partner needs to layer in some domain-specific rules and reviews. (cloud.google.com)
• Observability and regulator‑ready logs
  • It’s crucial to require audit logs that are stored immutably (think WORM/S3 Object Lock or something similar), plus you’ll want to have cryptographic commitments recorded on-chain for those important events (like consent updates). Don't forget to have them show you how they can reconstruct incidents from these logs.

Practical checks:

• Run a tabletop test: Simulate a de-identification process that didn't go as planned and see if you can roll back and re-issue verifiable consent artifacts in 24 hours or less.

---

9) Concrete RFP questions that separate experts from tourists

Ask Vendors to Respond with Artifacts--Not Just Answers:

When you’re reaching out to vendors, it’s super important to ask for more than just their answers. You want artifacts that can back up their claims. Here’s why and how to go about it:

Why Artifacts Are Important

• Proof Over Promises: It’s easy for vendors to say they deliver great results, but having actual artifacts helps you see the truth behind their words.
• Better Understanding: Artifacts give you a clearer picture of how the vendor operates. You can evaluate their work style and quality more effectively.
• Informed Decisions: When you have concrete examples to look at, it becomes a lot easier to make decisions that align with your needs.

What Types of Artifacts to Request

Here are some artifacts you might want to ask for:

• Case Studies: These provide insights into how the vendor tackled challenges for previous clients.
• Samples of Work: Whether it's design files, code snippets, or documentation, actual work samples help showcase skills.
• Client Testimonials: Positive feedback from past clients can really highlight a vendor's strengths.
• Demos or Trials: If applicable, requesting a demo or trial can give you firsthand experience with their product or service.

How to Ask for Artifacts

When you’re crafting your request, keep it straightforward yet friendly. Here’s a sample message you might send:

---

Subject: Request for Artifacts

Hi [Vendor's Name],

I hope this message finds you well! As we move forward in our evaluation process, I’d love to see some artifacts that showcase your work. Specifically, could you share any case studies, work samples, or client testimonials? This will really help us understand how you operate and what we can expect from your services.

Thanks so much for your help!

Best,
[Your Name]

---

By asking for artifacts in a friendly and professional way, you’ll be setting yourself up for a much more informed decision-making process.

• Architecture
  • Sketch out the complete data flow that goes from the patient app to the FHIR store, then to the ledger, and finally to the QHIN. Make sure to pinpoint which fields are written on-chain, if there are any, and explain why. Also, illustrate how this setup aligns with USCDI v3 APIs and meets TEFCA FHIR stages 2-3 by 2026. (himss.org)
• Compliance matrices
  • Share a mapping of NIST SP 800‑66r2 controls and whip up a workflow chart for FTC HBNR notifications related to your product. (csrc.nist.gov)
• Identity and credentials
  • Lay out the DID/VC 2.0 schemas for both provider credentialing and patient consent; don’t forget to identify the signature suite and revocation model you’re using. (w3.org)
• Ledger privacy and retention
  • Show off how you're using Hyperledger Fabric private-data collections with the PurgePrivateData() function, along with the retention policy documents tied to your record schedules. (hyperledger-fabric.readthedocs.io)
• Interoperability demos
  • Bring to life a working SMART v2 app that features granular scopes connecting to a US Core 8.x FHIR server. Plus, include a Bulk Data $export job that delivers de-identified ndjson. (build.fhir.org)
• DSCSA/pharma (if applicable)
  • Supply some evidence of EPCIS conformance and draft a transition plan that aligns with FDA exemptions dates for your trading partner roles. (fda.gov)
• Security
  • Provide validation evidence for FIPS 140 for the crypto modules you’re using to sign VCs and store keys (like an AWS KMS HSM certificate). There should also be a clear path laid out for aligning with HITRUST v11.x. (csrc.nist.gov)

---

10) Red flags we keep seeing (and how to counter them)

• “We put PHI on-chain, but it’s encrypted.”
  • Just because you've got encryption doesn’t mean all risks are off the table (think keys, future cryptanalysis, and re‑identification). It’s safer to stick with off‑chain PHI while using on‑chain proofs; make sure you have rock-solid key custody controls and FIPS‑validated modules in place. (csrc.nist.gov)
• “We’ll be TEFCA‑compatible later.”
  • TEFCA is already up and running, and new QHINs are joining the party. Don’t wait--check if you can integrate now by verifying actual endpoints and laying out a clear staged FHIR roadmap. (rce.sequoiaproject.org)
• “HIPAA doesn’t apply; we’re a wellness app.”
  • Not so fast! HBNR probably comes into play here. Be sure to ask for their HBNR decision memo along with their breach workflow. (ftc.gov)
• “We use zero‑knowledge everywhere.”
  • Sure, ZK is pretty impressive, but it’s not a one-size-fits-all solution. Push for a specific use case that includes measured proof sizes and latencies; otherwise, you might end up paying for unnecessary complexity. (jtie.stekom.ac.id)

---

11) Example: provider credentialing with verifiable credentials + VHDir + TEFCA

A Practical Pattern We Use:

• Source of truth: Bring in and validate license and board data into a VHDir-compliant FHIR store (Practitioner, OrganizationAffiliation, Endpoint). Check it out here: (build.fhir.org).
• Credential issuance: Create a W3C VC 2.0 “PractitionerCredential” that's signed using a FIPS-validated HSM key. For privacy, just publish a credential status list hash on-chain--no personal health information here! More details can be found at (w3.org).
• Verification: When other parties want to verify those VCs, they can do it off-chain and tap into TEFCA-connected APIs for clinical context. The ledger makes sure everything is tamper-proof with clear status and audit trails. Keep the scopes aligned with SMART v2 to stick to the least privilege principle. Get the scoop at (rce.sequoiaproject.org).
• Lifecycle: If a license changes, update the VHDir, revoke the old VC via the status list, and add an on-chain revocation event (hash only, of course). Make sure to keep the entire audit record in secure WORM storage that complies with HIPAA standards. More info can be found here: (csrc.nist.gov).

Outcome: Quicker onboarding, credentials that can be verified cryptographically, and a clear audit trail that stays in line with HIPAA and TEFCA guidelines.

---

12) Team interview prompts (use them verbatim)

• “Can you share your most recent ONC/USCDI upgrade? What went wrong and how did you handle it?” We’re looking for details on SMART v2 scope granularity and how it lines up with US Core. (himss.org)
• “How do you tackle the 45 CFR 164.526 amendments when working with an immutable log?” Look for solutions involving off-chain amendments, on-chain correction entries, and how you manage Fabric purges. (law.cornell.edu)
• “Which QHINs have you worked with, and can we see the logs or metrics?” They should be ready to name the specific QHINs they’ve engaged with and provide some data to back it up. (rce.sequoiaproject.org)
• “What does your de-identification QA process look like, especially when it comes to managing date-shift keys?” We expect to hear about strict controls and human review checkpoints, not just a bunch of API calls. (cloud.google.com)
• “Can you provide HBNR breach communication templates that are customized for our app?” They should have those templates ready to go. (ftc.gov)

---

13) What “great” looks like in 2025

• Architecture: We’re talking about PHI being handled off-chain; on-chain proofs and consent receipts are in play; there’s a FHIR-native data layer; Fabric PDCs that have purge and retention features; signing that’s backed by HSM; and we’ve got DID/VC 2.0 identity to round it off. (hyperledger-fabric.readthedocs.io)
• Interop: We’ve got a live plan for TEFCA connectivity; jumping into SMART v2; Bulk Data exports are up for grabs for analytics; and VHDir is on board for provider data governance. (rce.sequoiaproject.org)
• Compliance: We’re all about mapping to NIST 800‑66r2; there are HBNR workflows happening; reproductive health PHI guardrails are being put in place with some legal monitoring; plus, we’ve got the HITRUST v11.x roadmap to keep things in check. (csrc.nist.gov)

---

Final takeaway

Choosing a blockchain partner for healthcare in 2025 isn’t just about picking a specific chain anymore. It's really about making sure they have solid interoperability, smart privacy engineering, and controls that are ready for audits--all aligned with the latest regulations. Use the evaluation points we talked about earlier, ask for specific documents, and set a time limit for proof of concept around FHIR, TEFCA stages, and verifiable credentials. If a candidate can’t deliver on these clear requests in a hurry, it’s best to keep looking.